0
Article |

Treatment of Visceral Leishmaniasis With Meglumine and Allopurinol

ROSALIA RAGUSA, MD; ANDREA Di CATALDO, MD; PIERA SAMPERI, MD; GINA SCHILIRO, MD
Am J Dis Child. 1993;147(6):611-612. doi:10.1001/archpedi.1993.02160300017011.
Text Size: A A A
Published online

Sir.—Özsoylu1 presented the results of his study on visceral leishmaniasis and its treatment in children in the September 1992 issue of AJDC. We want to present our results with a different combined treatment: meglumine antimonate (as Glucantim) and allopurinol.

We describe 110 children with visceral leishmaniasis ranging in age from 6 months to 6 years. In most children, the disease had the typical picture of irregular fever, liver and spleen enlargement, anemia, and pancytopenia. All children were in satisfactory clinical condition; the diagnosis was confirmed by the presence of Leishmania donovani in bone marrow. Forty-six patients, diagnosed from 1973 through 1985, received conventional treatment with intramuscular meglumine antimonate alone (100 mg/kg daily) for 30 days.2

From 1986 through 1992, we used allopurinol and pentavalent antimony in the treatment of 64 patients admitted in our department who were diagnosed as having visceral leishmaniasis. They received allopurinol (25 mg/kg

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();